Fundamental Data for ABT

ABBOTT LAB(NYSE:ABT)

Abbott Laboratories is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals, nutritionals, and medical products, including devices and diagnostics. Their principal business is the discovery, development, manufacture, and sale of a broad and diversified line of health care products and services.

# Employees: 69000

Address: 100 Abbott Park Road,Abbott Park,IL,USA

Phone: 847-937-6l00

Fax: 847-937-1511

Website: www.abbott.com

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Miles D. White (Chmn.; C.E.O.; Dir.)

Thomas C. Freyman (Exec. V.P. Fin.; C.F.O.)

Glenn F. Tilton (Dir.)

Greg W. Linder (V.P.; Contro.)

William D. Smithburg (Dir.,)

Dividend

Ex-Dividend Date: 10/13/2009

Annual Dividend: $1.60

Current Dividend Yield: $2.98

Dividend Paid (3 months): $0.40

Indicated Dividend: $0.44

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 1/20/2010

Mean EPS (Next Qtr): $1.17

Mean EPS (Year): $3.71

Mean Estimate(Long Term): $11.27

P/E Ratio(Based on EPS estimate): 14.450

Number of Estimates: 19

Shares Performance

Period	ABT	Compare to S&P
YTD	0.51 %	-16.82 %
4 Weeks	4.54 %	3.41 %
12 Weeks	16.81 %	10.13 %

Shares Information

Analyst Coverage: Y

Avg Volume: 5785893

Shares Outstanding: 1545M

Market Cap: $82.92B

52 Week High: $57.25

52 Week Low: $41.52

P/E Ratio: 14.860

PEG Ratio: 1.280

Split: On 6/1/1998 ABT split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 2.22 %

EPS Growth in Last Year: 16.46 %

Sales Growth in Last Quarter: 3.55 %

Sales Growth in Last Quarter: 3.51 %

Financials

Qtr Book Value: $3.88

Cash Flow/Share: $11.85

Change in Payout Ratio: -0.020

Price/Sales: 2.770